CLINICAL_TRIALS
trial_result
· 2017-02-10
Clinical Trial Update: Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis [Phase 3]
Summary
Phase 3 pediatric open-label extension study of etanercept in pediatric plaque psoriasis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Pediatric Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2017-02-10